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Abstract
Background: Thymosin beta 4 (Tb4) is a member of beta-thymosins, a family of peptides that play essential roles in many
cellular functions. A recent study from our group suggested a role for Tb4 in the development of human salivary glands. The
aim of this study was to analyze the expression of Tb4 in the human gut during development, and in the adult.
Methodology/Principal Findings: Immunolocalization of Tb4 was studied in autoptic samples of tongue, oesophagus,
stomach, ileum, colon, liver and pancreas obtained from two human foetuses and two adults. Tb4 appeared unevenly
distributed, with marked differences between foetuses and adults. In the stomach, superficial epithelium was positive in
foetuses and negative in adults. Ileal enterocytes were strongly positive in the adult and weakly positive in the foetuses. An
increase in reactivity for Tb4 was observed in superficial colon epithelium of adults as compared with the foetuses. Striking
differences were found between foetal and adult liver: the former showed a very low reactivity for Tb4 while in the adult we
observed a strong reactivity in the vast majority of the hepatocytes. A peculiar pattern was found in the pancreas, with the
strongest reactivity observed in foetal and adult islet cells.
Significance: Our data show a strong expression of Tb4 in the human gut and in endocrine pancreas during development.
The observed differential expression of Tb4 suggests specific roles of the peptide in the gut of foetuses and adults. The
observed heterogeneity of Tb4 expression in the foetal life, ranging from a very rare detection in liver cells up to a diffuse
reactivity in endocrine pancreas, should be taken into account when the role of Tb4 in the development of human embryo is
assessed. Future studies are needed to shed light on the link between Tb4 and organogenesis.
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Introduction
Beta-thymosins (Tbs) constitute a highly conserved family of
actin-binding polypeptides [1], presenting a well conserved four-
aminoacid motif, corresponding to the sequence LKKT, which
interacts with actin, promoting or inhibiting actin assembly [2].
Thymosin beta-4 (Tb4) is the archetypal member of the beta-
thymosins family: it is a 43-aminoacid peptide, isolated from
human blood platelets [3] which forms a 1:1 complex with actin,
inhibits its polymerization [4], and acts as an extremely effective
actin-monomer sequestering peptide [5]. Tb4 has multiple
functions: it moonlights to repair injured tissues [6], has anti-
inflammatory efficacy in monocyte/macrophages [7], promotes
wound healing [8] and mediates angiogenesis [9]. Tb4 has been
also shown to play a relevant role during the development of
different neural cell types in the rat brain [10]. In particular, Tb4
plays a neurotrophic and antiapoptotic role during the develop-
ment of the nervous system [11]. In the embryo, reduced
myocardial Tb4 levels have been reported to cause a disrupted
coronary vasculogenesis and a number of cardiac defects [12].
During coronary vessels development, Tb4 should act on cardiac
stem cells, also known as epicardially derived cells (EPDCs) [13]
inducing their migration into the myocardium, where they
differentiate into either endothelial or smooth muscle cells [9].
The theory on the putative role of Tb4 in the physiological
development of embryos, as well as in vascularization and tissue
recovery in acute and chronic ischemia, has been reinforced by the
discovery that Tb4 is one of the most abundant factors secreted by
embryonic endothelial progenitor cells [14]. Recently a study from
our group evidenced a strong reactivity for Tb4 in developing
foetal salivary glands, with a switch from the acinar component to
the ductal cells in the adult [15]. Tb4 has also been identified as a
predominant transcript in intraepithelial lymphocytes (IEL) in the
murine gut [16], in which it could exert a relevant anti-
inflammatory effect by inhibiting neutrophilic infiltration [17].
On the basis of these data, suggesting a relevant role for Tb4
during the development of the foetus and the embryo, it seemed of
some interest to investigate the expression of the peptide in the
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to gain insights into the expression of Tb4 in the human
gastrointestinal tract during development.
Materials and Methods
Two human fetuses of 20 weeks (male) and 21 weeks (female) of
gestational age, and two adults 65 and 74 year old respectively
were the object of the present study. In each subject, we obtained,
at autopsy, multiple samples from the following segments of the
gut: tongue, oesophagus, stomach, ileum, colon. Samples were also
obtained from liver and pancreas. Tissue samples were fixed in
10% formalin, routinely processed and paraffin-embedded.
Immunohistochemistry was performed on 5 mm-thick sections,
using the labeled streptavidin-biotin complex system (LSAB2,
Dako) in a Dako Autostainer (DakoCytomation, Carpintera, CA,
USA). Heat-induced antigen retrieval was carried out by steaming
unstained sections in Target Retrieval Solution (Dako TRS
pH 6.1) for 30 min. Tissue sections were incubated (30 min at
room temperature) with the monoclonal anti-thymosin beta 4
antibody (Bachem, Bubendorf, Switzerland). Sections of a reactive
human adult lymph node with activated macrophages were used
as positive controls. As a negative control, we utilized sections of
foetal oesophagus: immunoistochemistry was performed using
isotype antibody (Fig. 1). The immunostaining was interpreted as
positive when at least 10% of cells expressed the antigen. The
positive expression was further categorized into focal (10–33%)
and diffuse (.33%).
All cases were independently reanalyzed by two pathologists
specialized in gastrointestinal pathology (GF, SN).
Ethics Statements
The study protocol and written consent forms were approved by
the Ethics Human Studies Committee of University Medical
Centre of Cagliari (according to the instructions of the declaration
of Helsinki). Full written consent forms were obtained from the
parents of the newborns and all rules were respected. For the
specimens from adults, we obtained written consent to revearch
use by their next of kin.
Results
The immunostaining for Tb4 appeared granular or homoge-
neously diffuse, always restricted to the cytoplasm of positive cells;
no nuclear reactivity was observed in this study. Reactivity for the
peptide was also observed, in some cases, in the interstitial spaces,
as fine granules, mainly located around the epithelial structures.
No significant differences were found in the immunoistochemical
pattern for Tb4 between the two foetuses and the two adults
analyzed.
Tongue
Foetus (20 weeks of gestation). The epithelium covering
the tongue appeared constantly negative in its deeper layers. The
superficial epithelial cells showed a diffuse immunoreactivity for
Tb4, localized in the cytoplasm (Fig. 2a). The underlying corion
was negative. A weak positivity was also observed in the muscular
cells.
Adult. The immunoistochemical pattern paralleled that
detected in the foetuses. The superficial layers of the stratified
Figure 1. Negative control. Foetal oesophagus immunostained by
using isotype antibody. L= oesophageal lumen. Arrows indicate the
surface epithelium.
doi:10.1371/journal.pone.0009111.g001
Figure 2. Immunohistochemical detection of thymosin b4i n
foetal and adult tongue. a) Foetal tongue: the superficial epithelial
cells (arrow) shows a diffuse immunoreactivity for Tb4, localized in the
cytoplasm. The underlying corion is negative. (Original Magnification
6250) b) Adult tongue: the superficial layers of the stratified epithelium
show a strong diffuse cytoplasmic reactivity for Tb4 (arrow). (Original
Magnification 6250)
doi:10.1371/journal.pone.0009111.g002
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for Tb4 (Fig. 2b).
Oesophagus
Foetus (21 weeks of gestation). The epithelium covering
the oesophageal lumen appeared negative. The oesophageal
lumen appeared coated with a thin Tb4-immunoreactive layer,
which resulted diffuse to the entire oesophageal lumen (Fig. 3a). A
weak reactivity for the peptide was observed in the muscular cells.
Adult. Immunoreactivity for Tb4 was restricted to epithelial
cells of the superficial layers covering the esophageal lumen. No
reactivity for Tb4 was found in the intermediated and deep layers
(Fig. 3b).
Stomach
Foetus (21 weeks of gestation). The gastric epithelium
showed the presence of Tb4-immunoreactive granules in the
cytoplasm of the majority of columnar cells. Immunoreactive
deposits were mainly found aggregated in the perinuclear regions.
Abundant deposits were also found dispersed throughout the
mucous covering the gastric surface (Fig. 4a).
Adult. Gastric mucosa was covered by a thin superficial layer
intensely reactive for Tb4 extending to gastric foveolae.
Immunoreactivity for Tb4 in gastric glands was restricted to
chief and oxyntic cells (Fig. 4b).
Ileum
Foetus (21 weeks of gestation). A granular reactivity for
Tb4 was detected in the epithelium covering the ileal villi, more
evident in the cytoplasm of mucous cells (Fig. 5a). A reactivity for
the peptide was also observed in the mucous occupying the
intestinal lumen.
Adult. A mild but diffuse reactivity for Tb4 was present in the
cytoplasm of enterocytes covering villi (Fig. 5b). Fine granular
deposits were also observed in the cytoplasm of mucous cells.
Colon
Foetus (21 weeks of gestation). Coarse granules
immunoreactive for Tb4 were observed in the cytoplasm of
superficial colon epithelial cells. No reactivity was found in the
Figure 3. Immunohistochemical detection of thymosin b4i n
foetal and adult oesophagus. a) Foetal oesophagus: the oesoph-
ageal lumen is coated with a thin Tb4-immunoreactive layer (arrow). A
weak reactivity for the peptide is observed in the muscular cells
(arrowhead). (Original Magnification 6400) b) Adult oesophagus:
immunoreactivity for Tb4 is restricted to epithelial cells of the superficial
layers (arrow). (Original Magnification 6400)
doi:10.1371/journal.pone.0009111.g003
Figure 4. Immunohistochemical detection of thymosin b4i n
foetal and adult stomach. a) Foetal stomach: Tb4-immunoreactive
granules are shown in the cytoplasm of the majority of columnar cells
(arrow). Tb4 granular deposits are also found in mucous covering the
gastric surface (arrowhead). (Original Magnification 6400) b) Adult
stomach: gastric mucosa appears covered by a thin superficial layer
intensely reactive for Tb4 (arrow). Immunoreactivity for Tb4 in gastric
glands is restricted to chief and oxyntic cells (arrowhaed). (Original
Magnification 6250)
doi:10.1371/journal.pone.0009111.g004
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reactivity for the peptide. A weak positivity was detected in the
nervous cells.
Adult. An intense and diffuse reactivity with coarse
sovranuclear granules immunoreactive for Tb4 were present in
the superficial and crypt epithelium. (Fig. 6b)
Liver
Foetus (21 weeks of gestation). No significant reactivity for
Tb4 was found in hepatocytes and in biliary ducts nor in biliary
epithelial cells of the ductal plate in the foetal liver examined in
this study. A weak reactivity was frequently observed in the red
blood cells in the dilated sinusoids. Only occasionally, scattered
large cells in immature portal tracts showed a strong Tb4
immunoreactivity (Fig. 7a).
Adult. The expression pattern for Tb4 changed completely in
immunostained adult livers. A strong granular immunoreactivity
was found in the cytoplasm of the majority of hepatocytes in all
acinar zones and in activated Kupffer cells (Fig. 7b). Portal tracts,
including bile ducts were constantly negative.
Pancreas
Foetus (20 weeks of gestation). Immunoreactivity for Tb4
appeared focal, mainly localized inside the islets of Langerhans. A
part of the endocrine cells showed the entire cytoplasm strongly
immunoreactive for the peptide. Few Tb4-reactive cells were also
present in the exocrine pancreas, inside the tubular structures,
intermingled among the tubular epithelium. A weak granular
reactivity for the peptide was also found inside the cytoplasm of the
tubular cells, a pattern suggestive for a secretion of Tb4 in the
pancreatic juice (Fig. 8a).
Adult. The distribution of Tb4 immunoreactivity paralleled
that observed in the foetus: the highest reactivity was observed in
the islet cells which showed diffuse fine cytoplasmic granular
deposits in the majority of endocrine cells. Only rare acinar cells
contained cytoplasmic vacuoles reactive for Tb4 (Fig. 8b).
Discussion
Tb4, the most abundant member in human cells of the thymosin
family, has been initially embraced as the ideal actin monomer-
Figure 5. Immunohistochemical detection of thymosin b4i n
foetal and adult ileum. a) Foetal ileum: a granular reactivity for Tb4 is
present in the epithelium covering ileal villi (arrow). A reactivity for the
peptide is also observed in the mucous occupying the intestinal lumen
(arrowhead). (Original Magnification 6400) b) Adult ileum: a mild
reactivity for Tb4 is present in the cytoplasm of enterocytes covering villi
(arrows). (Original Magnification 6250)
doi:10.1371/journal.pone.0009111.g005
Figure 6. Immunohistochemical detection of thymosin b4i n
foetal and adult colon. a) Foetal colon: coarse granules immuno-
reactive for Tb4 are observed in the cytoplasm of superficial enterocytes
(arrow). A weak positivity is detected in nervous cells (arrowhead).
(Original Magnification 6250) b) Adult colon: an intense and diffuse
reactivity for Tb4, characterized by coarse sovranuclear granules is
present in the superficial (arrow) and crypt epithelium (arrowhead).
(Original Magnification 6250)
doi:10.1371/journal.pone.0009111.g006
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regulate actin polymerization of non-muscle cells [19]. Further
data, suggesting a role of Tb4 in modulating stem cell migration
[9], activation [20] and inhibition [21], as well a relation between
Tb4 and integrin signalling [22] induced some authors to speak
about ‘‘the b-thymosin enigma’’ [9]. The oxidized form of Tb4,
thymosin beta 4 sulfoxide, has been demonstrated to have an
important anti-inflammatory activity inhibiting neutrophil chemo-
taxis in vitro [23] and in vivo [7].
This study represents the first comprehensive analysis of Tb4
immunoreactivity in the human gastrointestinal tract, pancreas
and liver of human foetus in comparison to adult. Interesting
differences were found between foetus and adult Tb4 immunore-
activity: in some organs, such as liver, the immunoreactivity of Tb4
was higher in the adult, while in others, such as endocrine
pancreas, it was lower. Differences in Tb4 expression between the
foetus and the adult have been previously reported by our group in
human salivary glands [15]. In that study developing major and
minor salivary glands showed a marked reactivity for Tb4, which
contrasted with the low levels of immunoreactivity observed in the
adult glands. In this study liver showed an opposite pattern,
characterized by low reactivity for the peptide in the intrauterine
life and much higher levels in the adult life. All together, these data
seem to indicate the existence of an exquisite cell type- and
differentiation stage-specific regulation and expression pattern of
Tb4 in the human gut and annexed glands during development.
As a consequence, Tb4 could play different roles in different
organs during the organogenesis, and these roles should change
during adult life.
Immunoreactivity for Tb4 was detected in all different intestinal
segments and in all glands examined, but with striking differences
among different sites: pancreas and liver of adults showed the
highest levels of reactivity for Tb4, while the lowest reactivity was
observed in the developing liver. A remarkable heterogeneity of
Tb4 immunoreactivity within the developing gastrointestinal tract
was observed, ranging from diffuse immunoreactivity in pancreas
and enterocytes, to peptide absence in the foetal hepatocytes. It
should be outlined that some differences observed in Tb4
immunoreactivity between fetuses and adult organs may be
Figure 7. Immunohistochemical detection of thymosin b4i n
foetal and adult liver. a) Foetal liver: no significant reactivity for Tb4
is found in hepatocytes and in ductal cells. Scattered large cells in
immature portal tracts show a strong immunoreactivity for the peptide
(arrow). (Original Magnification 6250) b) Adult liver: a strong granular
immunoreactivity for Tb4 is found in the cytoplasm of the majority of
hepatocytes in all acinar zones (arrow) and in activated Kupffer cells
(arrowhead). Portal tracts, including bile ducts are negative. (Original
Magnification 6400)
doi:10.1371/journal.pone.0009111.g007
Figure 8. Immunohistochemical detection of thymosin b4i n
foetal and adult pancreas. a) Foetal pancreas: immunoreactivity for
Tb4 is localized inside the islets of Langherans. Some of endocrine cells
show the entire cytoplasm strongly immunoreactive for the peptide
(arrows). Few Tb4-reactive cells are also present in the exocrine
pancreas, inside the tubular structures (arrowhead). (Original Magnifi-
cation 6400). b) Adult pancreas: the highest reactivity for Tb4 is
observed in Langherans islet cells, which show diffuse fine granular
deposits in their cytoplasm (arrows). (Original Magnification 6400).
doi:10.1371/journal.pone.0009111.g008
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chief and oxyntic cells, the site of Tb4 storage in the adult stomach,
are not well differentiated yet in the foetal stomach glands.
Noticeable interindividual differences during gut development,
regarding the intensity of the positivity for Tb4 and its subcellular
localization, were also observed (data not reported).
On the whole, the high amounts of Tb4 here reported in the
human gut during development are in agreement with previous
experimental studies on the role of Tb4 in organogenesis. High
levels of Tb4 mRNA had been indeed reported in early mouse
postimplantation embryos [24] and in the ventricular myocardium
of mice at embryonic day 10 [25]. The essential role of Tb4 in
heart development had been demonstrated by the generation of
mice with RNAi-mediated cardiac specific knockdown of Tb4.
Tb4-mutant hearts showed severe impairment in the mobiliza-
tion of cardiac progenitor cells, resulting in impaired cardiac
development and survival [26]. Our data clearly indicate a major
expression of Tb4 during the development of the human
gastrointestinal tract. Such a strong expression should be related
to relevant roles in gut development. The well known function of
Tb4 in the regulation of the equilibrium betwen globular and
filamentous actin [27] could partly explain the strong Tb4
immunoreactivity found in the cytoplasm of enterocytes in this
study. Tb4 has been hypothesized to also function as a sentinel of
the cell oxidative stress, its oxidation reflecting an oxidizing
environment that often correlates with cell damage [7]. Lymphoid
Tb4, a splice variant of Tb4 produced by intraepithelial
lymphocytes normally present in the cytoplasm of enterocytes,
has been shown to have a great capacity to reduce oxidative stress
[17]. Following this hypothesis, a strong immunohistochemical
reaction for Tb4 could be interpreted as a cell’s response to stress,
also considering that antibodies utilized in this study cannot
discriminate the oxidized Tb4 from the non-oxidized one.
Recently, Tb4 has been shown to be involved in regulating
phagocytosis of apoptotic cells mediated by stabilin-2 [28]. Given
the fundamental role of apoptosis in embryology, our finding of a
strong reactivity for Tb4 in the developing gut as well as in
developing salivary glands [15] reinforces the hypothesis of an
important role of Tb4 in organ development during embryogen-
esis. Future studies will be necessary to shed light on the link
between Tb4 and organogenesis, with particular emphasis on the
role plaied by the peptide in cell response to oxidative stress, in
apoptosis, in actin metabolism in the different phases of fetal,
embryo and adult life. The heterogeneity of Tb4 immunoreactivity
detected in different organs of gastrointestinal tract and the
differences observed between intrauterine and adult life should be
taken into account when the role of Tb4 in human physiology is
assessed.
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